Molecular biology and biochemistry of the endothelins
Trends in Pharmacological Sciences, ISSN: 0165-6147, Vol: 10, Issue: 9, Page: 374-378
1989
- 650Citations
- 36Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations650
- Citation Indexes650
- 650
- CrossRef439
- Captures36
- Readers36
- 27
Review Description
Endothelin-1 (ET-1), the first member of the newly discovered mammalian endothelin family of biologically active peptides, was originally identified as a 21 residue potent vasoconstrictor peptide in vascular endothelial cells. However, it has since been demonstrated to possess a wide variety of pharmacological activities in tissues both within and outside the cardiovascular system, and peptides with a striking similarity to ET-1 have been found to be the major toxic component of a snake venom. Moreover, recent studies have suggested that mammals including humans produce three distinct members of this peptide family, ET-1, ET-2 and ET-J, which may have different profiles of biological activity, and may act on distinct subtypes of endothelin receptor. Masashi Yanagisawa and Tomoh Masaki review the current status of the biochemistry and molecular biology of endothelin.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0165614789900114; http://dx.doi.org/10.1016/0165-6147(89)90011-4; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0024465081&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/2690429; https://linkinghub.elsevier.com/retrieve/pii/0165614789900114; http://dx.doi.org/10.1016/0165-6147%2889%2990011-4; https://dx.doi.org/10.1016/0165-6147%2889%2990011-4
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know